5AM Ventures V, L.P. - 27 Jun 2025 Form 4 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role: 10%+ Owner
Signature: 5AM Ventures V, L.P., By: 5AM Partners V, LLC, its General Partner, By /s/ Scott M. Rocklage, Managing Member
Issuer symbol: TRDA
Transactions as of: 27 Jun 2025
Net transactions value: -$866,632
Form type: 4
Filing time: 01 Jul 2025, 20:32:14 UTC
Previous filing: 02 Dec 2022
Next filing: 11 Jul 2025
SEC: View on sec.gov

Reporting Owners (6)

Name	Relationship	Address	Signature	Signature date	CIK
5AM Ventures V, L.P.	10%+ Owner	C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO	5AM Ventures V, L.P., By: 5AM Partners V, LLC, its General Partner, By /s/ Scott M. Rocklage, Managing Member	01 Jul 2025	0001674324
5AM Partners V, LLC	10%+ Owner	C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO	5AM Partners V, LLC, By /s/ Scott M. Rocklage, Managing Member	01 Jul 2025	0001791889
5AM Opportunities I, L.P.	10%+ Owner	C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO	5AM Opportunities I, L.P., By: 5AM Opportunities I (GP),LLC, its General Partner, By /s/ Kush Parmar, Managing Member	01 Jul 2025	0001753000
5AM Opportunities I (GP), LLC	10%+ Owner	C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO	5AM Opportunities I (GP), LLC, By /s/ Kush Parmar, Managing Member	01 Jul 2025	0001790778
ROCKLAGE SCOTT M	10%+ Owner	C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO	/s/ Scott M. Rocklage	01 Jul 2025	0001219014
Schwab Andrew J.	10%+ Owner	C/O 5AM VENTURE MANAGEMENT, LLC, 4 EMBARCADERO CENTER, SUITE 3110, SAN FRANCISCO	/s/ Andrew J. Schwab	01 Jul 2025	0001598549

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TRDA	Common Stock	Sale	$385,129	-55,735	-1.7%	$6.91	3,220,287	27 Jun 2025	Direct	F1
transaction	TRDA	Common Stock	Sale	$133,121	-19,265	-1.7%	$6.91	1,113,092	27 Jun 2025	By 5AM Opportunities I, L.P.	F2
transaction	TRDA	Common Stock	Sale	$126,566	-18,578	-0.58%	$6.81	3,201,709	30 Jun 2025	Direct	F1
transaction	TRDA	Common Stock	Sale	$43,751	-6,422	-0.58%	$6.81	1,106,670	30 Jun 2025	By 5AM Opportunities I, L.P.	F2
transaction	TRDA	Common Stock	Sale	$132,324	-18,578	-0.58%	$7.12	3,183,131	01 Jul 2025	Direct	F1
transaction	TRDA	Common Stock	Sale	$45,741	-6,422	-0.58%	$7.12	1,100,248	01 Jul 2025	By 5AM Opportunities I, L.P.	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.
F2	Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.

Content

Shares are held by 5AM Ventures V, L.P. ("5AM V"). 5AM Partners V, LLC ("5AM Partners") is the sole general partner of 5AM V. Dr. Kush Parmar, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners and may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM V. Each of 5AM Partners, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock held by 5AM V, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.

Shares are held by 5AM Opportunities I, L.P. ("Opportunities"). 5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held by Opportunities, except to the extent of its or his pecuniary interest therein. Dr. Parmar is a director of the Issuer and files separate Section 16 reports.